Diese Seite wurde automatisch übersetzt und die Genauigkeit der Übersetzung wird nicht garantiert. Bitte wende dich an die englische Version für einen Quelltext.

Machbarkeitsstudie und Pilot-Hybrid-Wirksamkeits-Implementierungsstudie zur universellen Prävention mütterlicher perinataler psychischer Störungen als normalisierte Routinepraxis (e-Perinatal-Pilot)

18. September 2026 aktualisiert von: Emma Motrico, University of Seville

Universelle Prävention mütterlicher perinataler psychischer Störungen und ihre Umsetzung als normalisierte Routinepraxis (e-Perinatal): Pilotstudie zur randomisierten Kontrolle (WP2)

This study is part of the e-Perinatal project, funded by the European Research Council. This research project will follow the first three phases recommended by the Medical Research Council (MRC) framework for the development and evaluation of complex interventions (Skivington et al., 2021).

The primary aim is to evaluate the feasibility and acceptability of implementing an innovative, personalized mobile health (mHealth) intervention designed for the universal prevention of perinatal mental disorders. Using a pilot, two-arm, cluster-randomized hybrid type 1 clinical trial, the study will assess key implementation outcomes and preliminary effectiveness indicators. The findings will inform the design of a future large clinical trial, intending to evaluate the effectiveness, cost-effectiveness, and implementation of the intervention as part of maternal care.

Studienübersicht

Detaillierte Beschreibung

This pilot clinical study investigates the feasibility, acceptability, and preliminary implementation and effectiveness of the e-Perinatal app, an innovative, personalized mobile health (mHealth) intervention designed for the universal prevention of perinatal mental disorders. The study will be conducted as a two-arm, cluster-randomized, hybrid type 1 trial within routine maternal care settings in primary healthcare centers in Andalusia, Spain. Participants will include pregnant and postpartum women (up to five months postpartum) and their partners. Primary healthcare centers will be randomized to either the intervention or control arm.

The primary objective is to evaluate the feasibility of integrating the e-Perinatal app into routine maternal care. Secondary objectives include assessing the acceptability of the intervention among women, partners, and healthcare professionals and exploring preliminary effectiveness outcomes, such as the incidence of perinatal depression and anxiety in women, changes in depressive and anxiety symptoms in both women and their partners, and potential impacts on infant health and development.

The study hypothesizes that the e-Perinatal intervention will be feasible and acceptable for pregnant and postpartum women, their partners, and healthcare professionals involved in routine maternal care.

Participants will be recruited from primary healthcare centres and allocated by cluster randomization to either the intervention group, which will receive the e-Perinatal app along with standard maternal care, or the control group, which will receive standard maternal care and monthly psychoeducational emails.

Studientyp

Interventionell

Einschreibung (Tatsächlich)

96

Phase

  • Unzutreffend

Kontakte und Standorte

Dieser Abschnitt enthält die Kontaktdaten derjenigen, die die Studie durchführen, und Informationen darüber, wo diese Studie durchgeführt wird.

Studienorte

    • Seville
      • Mairena del Aljarafe, Seville, Spanien, 41927
        • Primary Health Care Center Mairena del Aljarafe - Ciudad Expo

Teilnahmekriterien

Forscher suchen nach Personen, die einer bestimmten Beschreibung entsprechen, die als Auswahlkriterien bezeichnet werden. Einige Beispiele für diese Kriterien sind der allgemeine Gesundheitszustand einer Person oder frühere Behandlungen.

Zulassungskriterien

Studienberechtigtes Alter

18 Jahre und älter (Erwachsene, Älterer Erwachsener)

Akzeptiert gesunde Freiwillige

Nein

Studienberechtigte Geschlechter

Alle

Beschreibung

Inclusion criteria for mothers:

  • Must receive an invitation to participate from a healthcare professional at one of the participating primary healthcare centers
  • Must be pregnant for at least 16 weeks or have given birth within the last 5 months at the time of enrollment
  • Must be at least 18 years old
  • Must have access to a mobile phone and internet connection
  • Must be able to read, write, and understand Spanish
  • Must have a personal email account

Inclusion criteria for partners (or significant others):

  • Must receive an invitation to participate from a woman already enrolled in the study
  • Must be at least 18 years old
  • Must have access to a mobile phone and internet connection
  • Must be able to read, write, and understand Spanish
  • Must have a personal email account

Exclusion criteria for mothers:

  • Meet diagnostic criteria for anxiety or depression, as determined by a structured clinical interview
  • Be on a waiting list or currently receiving psychological or pharmacological treatment for any mental health or substance use condition

Exclusion criteria for partners (or significant others):

  • There are no exclusion criteria for partners

Studienplan

Dieser Abschnitt enthält Einzelheiten zum Studienplan, einschließlich des Studiendesigns und der Messung der Studieninhalte.

Wie ist die Studie aufgebaut?

Designdetails

  • Hauptzweck: Verhütung
  • Zuteilung: Zufällig
  • Interventionsmodell: Parallele Zuordnung
  • Maskierung: Single

Waffen und Interventionen

Teilnehmergruppe / Arm
Intervention / Behandlung
Experimental: Interventionsgruppe

The e-Perinatal intervention combines a personalized mobile health (mHealth) app with targeted training for healthcare professionals to support perinatal mental health within routine maternal care. Participants allocated to the intervention arm will use the app for a period of two months. The app offers psychoeducational content, video-guided physical activities, mindfulness exercises, mood-tracking tools, personalized recommendations through a rule-based algorithm, and social-community features. Healthcare professionals assigned to the intervention arm receive specialized training to integrate the app into their daily practice, enhancing their ability to promote and support mental health during the perinatal period.

Aktiver Komparator: Kontrollgruppe

Standard maternal care as routinely provided by the Andalusian public healthcare system (Spain). This includes scheduled visits with midwives, nurses, and pediatrician for maternal and infant health monitoring, as well as access to childbirth education programmes. Participants also receive monthly psychoeducational emails (two months) containing general information on perinatal mental health, pregnancy, and infant development. Healthcare professionals in this arm do not receive specialized training in perinatal mental health or in the use of digital interventions, and participants do not have access to the e-Perinatal app.

Was misst die Studie?

Primäre Ergebnismessungen

Ergebnis Maßnahme
Maßnahmenbeschreibung
Zeitfenster
Feasibility of the intervention
Zeitfenster: Measured at baseline and postintervention (2 months after baseline)

Calculation of participation rate, recruitment rate, and retention rate (follow-up rate) at all assessment points. Assessment method: Registration and follow-up records.

Measured at baseline and postintervention (2 months after baseline)
Early acceptability
Zeitfenster: Measured at enrollment

Number of eligible women and partners who agree to participate. Assessment method: Consent forms.

Measured at enrollment
Final acceptability
Zeitfenster: Measured at postintervention (2 months after baseline)

Evaluation of how appropriate, satisfactory, and feasible the intervention is after its implementation. Assessment method: Surveys and semi-structured interviews based on the Normalization Process Theory.

Measured at postintervention (2 months after baseline)

Sekundäre Ergebnismessungen

Ergebnis Maßnahme
Maßnahmenbeschreibung
Zeitfenster
Adoption
Zeitfenster: Measured before recruitment

Proportion of Primary Health Care (PHC) professionals who express their willingness to participate in the study among the total of potential professionals prior to the start of the intervention. Assessment method: Registration records.

Measured before recruitment
Fidelity
Zeitfenster: Measured at postintervention (2 months after baseline)

Measures adherence to the study protocol by PHC professionals. Assessment method: Surveys.

Measured at postintervention (2 months after baseline)
Early appropriateness
Zeitfenster: Measured at enrollment

Number of eligible women and number of partners invited to participate by women. Assessment method: Consent forms and recruitment records.

Measured at enrollment
Final appropriateness
Zeitfenster: Measured at postintervention (2 months after baseline)

Suitability and relevance of the intervention for the target population and context. Assessment method: Semi-structured interviews based on the Normalization Process Theory.

Measured at postintervention (2 months after baseline)
Cumulative incidence of maternal perinatal depression and maternal perinatal anxiety
Zeitfenster: Measured at enrollment and postintervention (2 months after baseline)

Measurement of the incidence of maternal perinatal depression and anxiety. Assessment method: The Mini International Neuropsychiatric Interview (MINI).

Measured at enrollment and postintervention (2 months after baseline)
Depressive symptoms
Zeitfenster: Measured at enrollment, postintervention (2 months after baseline), and follow-up (1 month after postintervention)

Changes in depressive symptoms. Assessment method: The Edinburgh Postnatal Depression Scale (EPDS), a 10-item self-report measure. Each item is scored from 0 to 3, with higher scores indicating more severe depressive symptoms.

Measured at enrollment, postintervention (2 months after baseline), and follow-up (1 month after postintervention)
Anxiety symptoms
Zeitfenster: Measured at enrollment, postintervention (2 months after baseline), and follow-up (1 month after postintervention)

Changes in anxiety symptoms. Assessment method: The General Anxiety Questionnaire (GAD-7), a 7-item self-report measure. Each item is scored from 0 to 3, with higher scores indicating more severe anxiety symptoms.

Measured at enrollment, postintervention (2 months after baseline), and follow-up (1 month after postintervention)
Postnatal post-traumatic stress
Zeitfenster: Measured at baseline

Presence of post-traumatic stress symptoms and clinical disorder in women or their partners after childbirth. Assessment method: Assessed using City Birth Trauma Scale (City-BiTS), a 31-item self-report measure. Some items are scored from 0 to 3 and others from 0 to 2, with higher scores indicating greater severity of postnatal post-traumatic stress.

Measured at baseline
Well-being
Zeitfenster: Measured at baseline, postintervention (2 months after baseline), and follow-up (1 month after postintervention)

Changes in subjective well-being. Assessment method: The Well-Being Index (WHO-5), a 5-item self-report measure. Each item is scored from 0 to 5, with higher scores indicating better subjective well-being.

Measured at baseline, postintervention (2 months after baseline), and follow-up (1 month after postintervention)

Andere Ergebnismessungen

Ergebnis Maßnahme
Maßnahmenbeschreibung
Zeitfenster
Organizational readiness for implementing change
Zeitfenster: Measured before recruitment

Organization's readiness for implementing changes in usual care. Assessment method: The Organizational Readiness Implementing Change (ORIC), a 12-item self-report measure. Each item is scored from 1 to 5, with higher scores indicating greater readiness for implementing change.

Measured before recruitment
App quality
Zeitfenster: Measured at postintervention (2 months after baseline)

Objective and subjective quality, and the perceived impact of the application. Assessment method: The User Version of the Mobile Application Rating Scale (u-MARS), a 26-item self-report measure. Each item is scored from 1 to 5, with higher scores indicating better app quality.

Measured at postintervention (2 months after baseline)
Implementation process
Zeitfenster: Measured at postintervention (2 months after baseline)

App implementation process from the perspective of healthcare professionals involved in implementing complex interventions. Assessment method: The Normalization Measure Development Questionnaire (NoMAD), a 20-item self-report measure. Each item is scored from 1 to 5, with higher scores indicating more effective implementation processes.

Measured at postintervention (2 months after baseline)
Barriers and facilitators
Zeitfenster: Measured at postintervention (2 months after baseline)

Identifies barriers and facilitators impacting the integration of the intervention into routine healthcare, drawing from the experiences of users and healthcare professionals. Assessment method: Semi-structured interviews following the Normalization Process Theory (NPT) framework

Measured at postintervention (2 months after baseline)
PHC characteristics
Zeitfenster: Measured before recruitment

Size of the population where the PHC is located and number of PHC professionals. Assessment method: Questionnaire developed by the research team

Measured before recruitment
Reasons for dropout
Zeitfenster: Measured at postintervention (2 months after baseline)

Number and reasons (e.g., experienced miscarriage or stillbirth, lack of engagement with the app) for dropout among women and their partners. Assessment method: Records and semi structured interviews.

Measured at postintervention (2 months after baseline)
Antenatal and postnatal risks
Zeitfenster: Measured at baseline

Measures both antenatal and postnatal risk factors. Assessment method: The Antenatal Risk Questionnaire (ANRQ-R), a 11-item self-report measure. Some items are scored from 1 to 5 and others are scored on categorical scale, with higher scores indicating greater risk.

Measured at baseline
Maternal antenatal attachment
Zeitfenster: Measured at baseline

Measures the level of maternal antenatal attachment to the baby. Assessment method: The Maternal Antenatal Attachment Scale (MAAS), a 19-item self-report measure. Each item is scored from 1 to 5, with higher scores indicating stronger maternal antenatal attachment.

Measured at baseline
Paternal antenatal attachment
Zeitfenster: Measured at baseline

Measures the level of paternal antenatal attachment to the baby. Assessment method: The Paternal Antenatal Attachment Scale (PAAS), a 16-item self-report measure. Each item is scored from 1 to 5, with higher scores indicating stronger paternal antenatal attachment.

Measured at baseline
Maternal postnatal attachment
Zeitfenster: Measured at baseline

Measures the level of maternal postnatal attachment to the baby. Assessment method: The Maternal Postnatal Attachment Scale (MPAS), a 19-item self-report measure. Each item is scored from 1 to 5, with higher scores indicating stronger maternal postnatal attachment.

Measured at baseline
Paternal postnatal attachment
Zeitfenster: Measured at baseline

Measures the level of postnatal attachment to the baby in both mothers and fathers. Assessment method: The Paternal Postnatal Attachment Scale (PPAS), a 19-item self-report measure. Each item is scored from 1 to 5, with higher scores indicating stronger paternal postnatal attachment.

Measured at baseline
Infant temperament
Zeitfenster: Measured at baseline

Measures various aspect of infant temperament. Assessment method: The Infant Behavior Questionnaire-Revised Short Form (IBQ-R SF), a 37-item self-report measure. Each item is scored from 1 to 7, with higher scores indicating a higher frequency of the specified temperament behavior.

Measured at baseline
Coparenting dynamics
Zeitfenster: Measured at baseline

Measures the dynamics of coparenting relationships. Assessment method: The Coparenting Relationship Scale (CRS), a 14-item self-report measure. Each item is scored from 0 to 6, with higher scores indicating more positive coparenting dynamics.

Measured at baseline
Parental role perception
Zeitfenster: Measured at baseline

Measures parents' perception of their competence in the parental role. Assessment method: The Parental Sense of Competence scale (PSOC), a 21-item self-report measure. Each item is scored from 1 to 6, with higher scores indicating a stronger sense of parental competence.

Measured at baseline
Infant development
Zeitfenster: Measured at baseline

Measures various developmental milestones in infants.

Measured at baseline
Partnership quality
Zeitfenster: Measured at baseline

Measures the quality of the marital or partnership relationship. Assessment method: The Quality of Marriage Index (QMI), a 6-item self-report measure. Some items are scored from 1 to 7 and others from 1 to 10, with higher scores indicating better relationship quality.

Measured at baseline
Sleep quality
Zeitfenster: Measured at baseline

Measures the quality of sleep among participants. Assessment method: The Pittsburgh Sleep Quality Index (PSQI), a 19-item self-report measure. Some items are scored from 0 to 3 and some on a categorical scale, with higher scores indicating poorer sleep quality.

Measured at baseline
Life quality
Zeitfenster: Measured at baseline

Measures the overall quality of life. Assessment method: The European Quality of Life-5 Dimensions-5 Levels (EuroQol-5D-5L), a 5-item self-report measure. Each item is scored from 1 to 5, with higher scores indicating worse quality of life.

Measured at baseline
Maternal physical activity levels
Zeitfenster: Measured at baseline

Measures physical activity levels in pregnant women and mothers. Assessment method: The Pregnancy Physical Activity Questionnaire (PPAQ), a 33-item self-report measure. Each item is scored from 0 to 5, with higher scores indicating higher levels of physical activity.

Measured at baseline
Paternal physical activity levels
Zeitfenster: Measured at baseline

Measures physical activity levels in fathers. Assessment method: The International Physical Activity Questionnaire (IPAQ), a 7-item self-report measure. Each item is scored on a categorical scale, with higher scores indicating higher levels of physical activity.

Measured at baseline
Physical condition
Zeitfenster: Measured at baseline

Measures overall physical condition and the main components (i.e., cardiorespiratory fitness, muscular strength, speed-agility, and flexibility) in pregnant women and mothers. Assessment method: The International FItness Scale (IFIS), a 5-item self-report measure. Each item is scored from 1 to 5, with higher scores indicating better physical condition.

Measured at baseline
Mood state
Zeitfenster: Measured at baseline

Measures positive and negative affect states. Assessment method: The Positive and Negative Affect Schedule (PANAS), a 20-item self-report measure. Each item is scored from 1 to 7, with higher scores indicating a higher frequency of the specified temperament behavior.

Measured at baseline
Basic psychological needs
Zeitfenster: Measured at baseline

Measures the satisfaction and frustration of basic psychological needs. Assessment method: The Basic Psychological Need Satisfaction and Frustration Scale - Short Form (BPNSFS), a 12-item self-report measure. Each item is scored from 1 to 5, with higher scores indicating a higher need satisfaction (i.e., need satisfaction subscale) or a higher need frustration (i.e., need frustration subscale).

Measured at baseline
Economic data
Zeitfenster: Measured at postintervention (2 months after baseline)

Measures healthcare service utilization and sick leave days over the previous year among participating women.

Assessment method: a post hoc semi-structured interview that collects information on emergency visits, hospital admissions, primary care visits (e.g., nurse, midwife, social worker), secondary care visits, and consultations with specialists.

Measured at postintervention (2 months after baseline)

Mitarbeiter und Ermittler

Hier finden Sie Personen und Organisationen, die an dieser Studie beteiligt sind.

Publikationen und hilfreiche Links

Die Bereitstellung dieser Publikationen erfolgt freiwillig durch die für die Eingabe von Informationen über die Studie verantwortliche Person. Diese können sich auf alles beziehen, was mit dem Studium zu tun hat.

Nützliche Links

Studienaufzeichnungsdaten

Diese Daten verfolgen den Fortschritt der Übermittlung von Studienaufzeichnungen und zusammenfassenden Ergebnissen an ClinicalTrials.gov. Studienaufzeichnungen und gemeldete Ergebnisse werden von der National Library of Medicine (NLM) überprüft, um sicherzustellen, dass sie bestimmten Qualitätskontrollstandards entsprechen, bevor sie auf der öffentlichen Website veröffentlicht werden.

Haupttermine studieren

Studienbeginn (Tatsächlich)

2. Mai 2025

Primärer Abschluss (Tatsächlich)

11. November 2025

Studienabschluss (Tatsächlich)

31. Januar 2026

Studienanmeldedaten

Zuerst eingereicht

8. Oktober 2024

Zuerst eingereicht, das die QC-Kriterien erfüllt hat

11. Oktober 2024

Zuerst gepostet (Tatsächlich)

15. Oktober 2024

Studienaufzeichnungsaktualisierungen

Letztes Update gepostet (Tatsächlich)

23. September 2026

Letztes eingereichtes Update, das die QC-Kriterien erfüllt

18. September 2026

Zuletzt verifiziert

1. September 2026

Mehr Informationen

Begriffe im Zusammenhang mit dieser Studie

Andere Studien-ID-Nummern

  • SICEIA-2024-001659
  • 101042139 (Andere Zuschuss-/Finanzierungsnummer: European Research Council (ERC))

Plan für individuelle Teilnehmerdaten (IPD)

Planen Sie, individuelle Teilnehmerdaten (IPD) zu teilen?

NEIN

Arzneimittel- und Geräteinformationen, Studienunterlagen

Studiert ein von der US-amerikanischen FDA reguliertes Arzneimittelprodukt

Nein

Studiert ein von der US-amerikanischen FDA reguliertes Geräteprodukt

Nein

Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .

Abonnieren